Dr. David Lanfear, MD

• Cardiology

• Advanced Heart Failure & Transplant Cardiology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Michigan / Medical Center

  Medical School

• Washington University/barnes Jewish Hospital

  Residency Hospital, 2005

• Effectiveness of Beta Blockers in Patients with and without a History of Myocardial Infarction, 2020-05-22

• Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with Elamipretide, 2018-06-27

• Impact of Socioeconomic Factors on Patient Desire for Early LVAD Therapy Prior to Inotrope Dependence, 2019-12-04

• The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial, 2022-02-28

• Association of Genetic Variation with Gene Expression and Protein Abundance within the Natriuretic Peptide Pathway, 2013-07-09

• Progress toward genetic tailoring of heart failure therapy, 2010-12-20

• Comparison of Renal Predictors for In-Hospital and Post-Discharge Mortality after Hospitalized Heart Failure, 2013-06-27

• Effect of Ezetimibe on Major Atherosclerotic Disease Events and All-Cause Mortality, 2012-12-04

• Relation of Worsened Renal Function during Hospitalization for Heart Failure to Long-Term Outcomes and Rehospitalization, 2010-12-27

• Insulin Resistance is Associated with Significant Clinical Atherosclerosis in Non-Diabetic Patients with Acute Myocardial Infarction, 2013-07-18

• Genome-wide Approach to Identify Novel Candidate Genes for Beta Blocker Response in Heart Failure Using an Experimental Model, 2013-06-17

• Integrative approach identifies corticosteroid response variant in diverse populations with asthma, 2018-10-24

• Functional dynamic genetic effects on gene regulation are specific to particular cell types and environmental conditions, 2021-05-14

• Factors predicting inhaled corticosteroid responsiveness in African American patients with asthma, 2010-09-03

• Prognostic value of Cardiopulmonary Exercise Testing in Heart Failure with preserved Ejection Fraction. The Henry F ord Hosp IT al C ardio P ulmonary E X ercise Testing (FIT-CPX) Project, 2016-01-12

• Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid non-adherence, 2011-10-21

• Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure, 2009-07-29

• Relationship of Tricuspid Repair at the time of Left Ventricular Assist Device Implantation and Survival, 2014-11-29

• High Rates of False-Positive Hepatitis C Antibody Tests Can Occur After Left Ventricular Assist Device Implantation, 2013-09-20

• Aldehyde Dehydrogenase 2 Activator Augments the Beneficial Effects of Empagliflozin in Mice with Diabetes-Associated HFpEF, 2022-09-09

• Comparing methods for identifying patients with heart failure using electronic data sources, 2009-12-18

• Dual specificity phosphatase-1 as a pharmacogenetic modifier of inhaled steroid response among asthma patients, 2010-07-31

• Gap between clinical-guidelines and practice: The case of aldosterone-antagonists in patients with Myocardial Infarction, 2013-12-28

• Genetics of heart rate in heart failure patients (GenHRate), 2019-05-21

• Cytochrome P450 Gene Variants, Race, and Mortality Among Clopidogrel Treated Patients Following Acute Myocardial Infarction, 2014-04-24

• Failure to Reassess Ejection Fraction after Acute Myocardial Infarction in Potential Implantable Cardioverter Defibrillator Candidates: Insights from the Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) Registry, 2013-09-05

• Genetic variation in the natriuretic peptide system and heart failure, 2008-10-11

• Plasma Proteomic Profile Predicts Survival in Heart Failure with Reduced Ejection Fraction, 2021-05-17

• Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure with Reduced Ejection Fraction: DEFINE-HF, 2022-05-23

• Prognostic Value Of Serial N Terminal-Pro Brain Natriuretic Peptide Testing In Patients With Acute Myocardial Infarction, 2017-04-27

• Suppression Tumorigenicity 2 (ST2) Turbidimetric Immunoassay Compared to Enzyme-Linked Immunosorbent Assay in Predicting Survival in Heart Failure Patients with Reduced Ejection Fraction, 2020-09-12

• Relationship between recent short-actingß-agonist use and subsequent asthma exacerbations, 2009-02-09

• Association of Anti-Diabetic Medications Targeting the Glucagon-Like Peptide-1 Pathway and Heart Failure Events in Patients with Diabetes, 2014-10-28

• Comparison of Beta Blocker Effectiveness in Heart Failure Patients with Preserved Ejection Fraction vs. those with Reduced Ejection Fraction, 2013-01-24

• Genetic Factors Influencing B-type Natriuretic Peptide-Mediated Production of Cyclic Guanosine Monophosphate and Blood Pressure Effects in Heart Failure Patients, 2015-11-20

• Factors influencing patient willingness to participate in genetic research after a myocardial infarction, 2011-06-15

• Interaction betweenPPARAgenotype and ß-blocker treatment influences clinical outcomes following acute coronary syndromes, 2008-10-23

• Genetic variation inBAFFand asthma exacerbations among African American individuals, 2012-06-22

• Policies and Events Affecting Prescription Opioid Use for Non-Cancer Pain Among an Insured Patient Population, 2016-01-12

• BNP and Precision Medicine Tip of an Iceberg*, 2021-06-28

• Type of Beta-blocker Use Among Patients with Versus without Diabetes after Myocardial Infarction, 2014-06-09

• Performance of the Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) Score in African American Patients Compared to Whites, 2019-07-03

• Relationship of Loop Diuretic Dosing and Acute Changes in Renal Function during Hospitalization for Heart Failure, 2011-11-22

• Race and Association of ACE/ARB Exposure with Outcome in Heart Failure, 2015-02-06

• Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: A time-updated propensity analysis, 2010-07-20

• Adrenergic-pathway Gene Variants Influence ß-Blocker-related Outcomes after Acute Coronary Syndrome in a Race-specific Manner, 2012-06-13

• Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients, 2017-08-17

• Risk Prediction in Transition: MAGGIC Score Performance at Discharge and Incremental Utility of Natriuretic Peptides, 2019-11-18

• Association of Beta Blocker Exposure with Outcomes in Heart Failure Patients Differs between African American and White Patients, 2012-01-19

• Assessing differences in inhaled corticosteroid response by self-reported race-ethnicity and genetic ancestry among individuals with asthma, 2016-03-22

• Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients withinCYP2C19genotype groups following acute myocardial infarction, 2014-07-08

• Association of Arginine Vasopressin Levels with Outcomes and the Effect of V2 Blockade in Patients Hospitalized for Heart Failure with Reduced Ejection Fraction: Insights from the EVEREST Trial, 2012-12-12

• A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma, 2010-05-31

• Gene-based association identifiesSPATA13-AS1as a pharmacogenomic predictor of inhaled short-acting beta-agonist response in multiple population groups, 2014-01-14